Amgen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

26,700

Employees26,700

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

26,700

Employees26,700

AMGN Key Statistics

Market cap

166.82B

Market cap166.82B

Price-Earnings ratio

39.81

Price-Earnings ratio39.81

Dividend yield

3.10%

Dividend yield3.10%

Average volume

2.54M

Average volume2.54M

High today

$322.60

High today$322.60

Low today

$308.72

Low today$308.72

Open price

$313.39

Open price$313.39

Volume

9.64M

Volume9.64M

52 Week high

$329.72

52 Week high$329.72

52 Week low

$211.71

52 Week low$211.71

AMGN News

Yahoo Finance 3h

Why Amgen Stock Zoomed Nearly 12% Higher Today - Yahoo Finance

Amgen (NASDAQ: AMGN) released its latest set of quarterly results after market hours Thursday, and investors rewarded the pharmaceutical company the following d...

Yahoo Finance 4h

Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market - Yahoo Finance

Amgen's (AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday. CEO Bob Bradway...

Barron's 4h

These Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More

Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weig...

Analyst ratings

52%

of 31 ratings

Buy

51.6%

Hold

41.9%

Sell

6.5%

More AMGN News

Yahoo Finance 4h

The two ways Amgen's new weight-loss drug can stand out - Yahoo Finance

Pharmaceutical stock Amgen (AMGN) is rising following early positive results from the development of its new GLP-1 weight-loss drug, MariTide. Yahoo Finance Sen...

Yahoo Finance 6h

Analyst unveils Amgen stock price target after weight-loss drug data - Yahoo Finance

If Soranus of Ephesus were alive today he'd be mighty surprised. Like his modern-day counterparts in the medical field, the 2nd Century Greek physician conside...

ABC News 8h

Apple, Amgen rise; Expedia, Fortinet fall, Friday, 5/3/2024 - ABC News

Stocks that are trading heavily or have substantial price changes Friday: Apple, Amgen rise; Expedia, Fortinet fall The Associated Press By The Associated Pre...

Seeking Alpha 9h

William Blair, Barclays upgrade Amgen following GLP-1 drug update

William Blair has upgraded Amgen to outperform in the wake of encouraging remarks by management about the company’s weight-loss drug candidate MariTide and ahea...

Reuters 9h

US STOCKS-Wall St rallies after soft jobs data allays rate jitters

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * U.S. job growth slows in April * Apple jumps after...

CNBC 10h

Here's what's driving Friday's stock action in Apple, Coterra and Eli Lilly

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. U.S. stocks...

Benzinga 10h

Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value

Loading... Loading... Amgen Inc AMGN reported first-quarter (Q1) earnings Thursday, touting adjusted EPS of $3.96, which beat the analyst consensus estimate of...